Last 12 months
Inside the activity.
2 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 700 | $39.53 | $27,671.00 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 3 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370,910 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.515 to $39.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 20,584 | $38.73 | $797,265.66 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 2 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,371,610 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.49 to $39.478. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 11,570 | $38.28 | $442,841.75 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 1 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,392,194 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.49 to $38.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:36 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 1,600 | $39.21 | $62,732.96 |
DisclosureSEC source: 0001209191-21-017534 · doc4.xml · nonDerivative · entry 2 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,230 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.075 to $39.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:36 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 4,332 | $38.62 | $167,300.54 |
DisclosureSEC source: 0001209191-21-017534 · doc4.xml · nonDerivative · entry 1 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,830 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.06 to $38.945. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:35 UTC |
Miller EdwardGeneral Counsel
|
SaleCommon Stock | 2,200 | $39.14 | $86,107.56 |
DisclosureSEC source: 0001209191-21-017529 · doc4.xml · nonDerivative · entry 2 Miller Edward · CIK 0001619252 · General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 192,811 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.93 to $39.475. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:35 UTC |
Miller EdwardGeneral Counsel
|
SaleCommon Stock | 3,800 | $38.58 | $146,591.84 |
DisclosureSEC source: 0001209191-21-017529 · doc4.xml · nonDerivative · entry 1 Miller Edward · CIK 0001619252 · General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 195,011 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.92 to $38.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:34 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 3,159 | $39.18 | $123,757.62 |
DisclosureSEC source: 0001209191-21-017527 · doc4.xml · nonDerivative · entry 2 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,462,167 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.90 to $39.615. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:34 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 6,359 | $38.46 | $244,571.59 |
DisclosureSEC source: 0001209191-21-017527 · doc4.xml · nonDerivative · entry 1 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,465,326 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.89 to $38.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 23, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 200 | $41.19 | $8,238.00 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 8 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 968,619 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.16 to $41.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 23, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 1,801 | $40.40 | $72,769.04 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 7 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 968,819 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.01 to $40.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 23, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 3,688 | $39.46 | $145,529.22 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 6 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 970,620 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.01 to $39.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 23, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 2,800 | $38.75 | $108,499.44 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 5 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 974,308 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.01 to $38.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 600 | $40.97 | $24,582.48 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 8 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,403,764 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.77 to $41.225. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 2,300 | $40.13 | $92,293.94 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 7 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,404,364 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.76 to $40.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 4,825 | $39.11 | $188,691.76 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 6 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,406,664 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.75 to $39.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 1,125 | $38.33 | $43,116.08 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 5 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,411,489 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.74 to $38.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:44 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 700 | $40.32 | $28,227.01 |
DisclosureSEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 5 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,162 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.03 to $40.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:44 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 1,418 | $39.18 | $55,556.39 |
DisclosureSEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 4 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,862 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.75 to $39.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:43 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 800 | $40.56 | $32,447.52 |
DisclosureSEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 6 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,471,685 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.21 to $41.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:43 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 1,907 | $39.59 | $75,497.75 |
DisclosureSEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 5 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,472,485 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.12 to $40.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 00:43 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 1,492 | $38.83 | $57,931.23 |
DisclosureSEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 4 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,474,392 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.11 to $39.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 310 | $43.38 | $13,446.41 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 4 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 977,108 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.34 to $43.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 8,779 | $42.80 | $375,745.59 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 3 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 977,418 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.31 to $43.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 2,334 | $41.58 | $97,054.49 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 2 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 986,197 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.25 to $42.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 380 | $43.40 | $16,492.80 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 4 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,412,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.34 to $43.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 11,050 | $42.80 | $472,906.85 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 3 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,412,994 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.31 to $43.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 2,891 | $41.58 | $120,214.72 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 2 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,424,044 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.25 to $42.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:44 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 2,200 | $42.82 | $94,200.92 |
DisclosureSEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 3 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,280 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.42 to $43.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:44 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 600 | $41.53 | $24,916.98 |
DisclosureSEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 2 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,480 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.27 to $41.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:43 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 4,506 | $42.84 | $193,034.34 |
DisclosureSEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 3 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,475,884 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.38 to $43.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:43 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 1,200 | $41.54 | $49,846.08 |
DisclosureSEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 2 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,480,390 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.28 to $41.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 00:43 UTC |
Hagen Brett RChief Accounting Officer
|
SaleCommon Stock | 800 | $43.14 | $34,509.04 |
DisclosureSEC source: 0001209191-21-013482 · doc4.xml · nonDerivative · entry 1 Hagen Brett R · CIK 0001681782 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,765 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.39. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 19:42 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 11,990 | $41.78 | $500,935.01 |
DisclosureSEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 1 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 988,531 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.31 to $42.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 00:44 UTC |
Vera JuanDirector
|
SaleCommon Stock | 13,233 | $41.79 | $553,011.04 |
DisclosureSEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 1 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,426,935 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.34 to $42.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 00:44 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 4,165 | $41.71 | $173,719.65 |
DisclosureSEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 1 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,080 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.41 to $42.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 00:43 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 7,541 | $41.75 | $314,867.67 |
DisclosureSEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 1 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,481,590 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.41 to $42.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 08:38 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 2,982 | $41.49 | $123,731.83 |
DisclosureSEC source: 0000899243-21-007328 · doc4.xml · nonDerivative · entry 3 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,000,521 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.85 to $41.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 08:38 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 2,800 | $40.34 | $112,950.04 |
DisclosureSEC source: 0000899243-21-007328 · doc4.xml · nonDerivative · entry 2 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,003,503 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.85 to $40.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 08:38 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 975 | $39.68 | $38,683.91 |
DisclosureSEC source: 0000899243-21-007328 · doc4.xml · nonDerivative · entry 1 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,006,303 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.83 to $39.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:44 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 1,300 | $41.50 | $53,950.13 |
DisclosureSEC source: 0000899243-21-007336 · doc4.xml · nonDerivative · entry 3 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,489,131 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.14 to $41.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:44 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 1,100 | $40.44 | $44,484.11 |
DisclosureSEC source: 0000899243-21-007336 · doc4.xml · nonDerivative · entry 2 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,490,431 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.09 to $40.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:44 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 300 | $39.20 | $11,760.00 |
DisclosureSEC source: 0000899243-21-007336 · doc4.xml · nonDerivative · entry 1 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,491,531 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.94 to $39.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:44 UTC |
Hagen Brett RChief Accounting Officer
|
SaleCommon Stock | 541 | $40.39 | $21,852.67 |
DisclosureSEC source: 0000899243-21-007335 · doc4.xml · nonDerivative · entry 2 Hagen Brett R · CIK 0001681782 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,565 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.06 to $40.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:44 UTC |
Hagen Brett RChief Accounting Officer
|
SaleCommon Stock | 200 | $39.36 | $7,871.00 |
DisclosureSEC source: 0000899243-21-007335 · doc4.xml · nonDerivative · entry 1 Hagen Brett R · CIK 0001681782 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,106 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.05 to $39.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:41 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 750 | $41.50 | $31,125.68 |
DisclosureSEC source: 0000899243-21-007332 · doc4.xml · nonDerivative · entry 3 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,245 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.22 to $41.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:41 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 800 | $40.44 | $32,349.44 |
DisclosureSEC source: 0000899243-21-007332 · doc4.xml · nonDerivative · entry 2 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,995 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.22 to $40.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:41 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 535 | $39.83 | $21,311.67 |
DisclosureSEC source: 0000899243-21-007332 · doc4.xml · nonDerivative · entry 1 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,795 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.21 to $40.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:41 UTC |
Vera JuanDirector
|
SaleCommon Stock | 3,710 | $41.49 | $153,923.08 |
DisclosureSEC source: 0000899243-21-007331 · doc4.xml · nonDerivative · entry 3 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,440,168 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.04 to $41.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 13:41 UTC |
Vera JuanDirector
|
SaleCommon Stock | 4,032 | $40.44 | $163,069.40 |
DisclosureSEC source: 0000899243-21-007331 · doc4.xml · nonDerivative · entry 2 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,443,878 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.93 to $40.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.